BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21169405)

  • 1. NKX2.2 suppresses self-renewal of glioma-initiating cells.
    Muraguchi T; Tanaka S; Yamada D; Tamase A; Nakada M; Nakamura H; Hoshii T; Ooshio T; Tadokoro Y; Naka K; Ino Y; Todo T; Kuratsu J; Saya H; Hamada J; Hirao A
    Cancer Res; 2011 Feb; 71(3):1135-45. PubMed ID: 21169405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
    Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
    J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
    Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
    Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
    Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse induced glioma-initiating cell models and therapeutic targets.
    Kondo T
    Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
    Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
    Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
    Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
    Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
    Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells are enriched in the side population cells in a mouse model of glioma.
    Harris MA; Yang H; Low BE; Mukherjee J; Guha A; Bronson RT; Shultz LD; Israel MA; Yun K
    Cancer Res; 2008 Dec; 68(24):10051-9. PubMed ID: 19074870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 is essential for glioblastoma cancer stem cell maintenance.
    Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I
    Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
    Rahme GJ; Luikart BW; Cheng C; Israel MA
    Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP2 promotes glioma tumor stem cell expansion and survival.
    Hsieh D; Hsieh A; Stea B; Ellsworth R
    Biochem Biophys Res Commun; 2010 Jun; 397(2):367-72. PubMed ID: 20515648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
    Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
    J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eva1 Maintains the Stem-like Character of Glioblastoma-Initiating Cells by Activating the Noncanonical NF-κB Signaling Pathway.
    Ohtsu N; Nakatani Y; Yamashita D; Ohue S; Ohnishi T; Kondo T
    Cancer Res; 2016 Jan; 76(1):171-81. PubMed ID: 26677976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.